Inflammation and liver cancer: new molecular links - PubMed (original) (raw)
Review
Inflammation and liver cancer: new molecular links
C Berasain et al. Ann N Y Acad Sci. 2009 Feb.
Abstract
A connection between inflammation and cancer has been long suspected. Epidemiological studies have established that many tumors occur in association with chronic infectious diseases, and it is also known that persistent inflammation in the absence of infections increases the risk and accelerates the development of cancer. One clear example of inflammation-related cancer is hepatocellular carcinoma (HCC). HCC is a type tumor that slowly unfolds on a background of chronic inflammation mainly triggered by exposure to infectious agents (hepatotropic viruses) or to toxic compounds (ethanol). The molecular links that connect inflammation and cancer are not completely known, but evidences gathered over the past few years are beginning to define the precise mechanisms. In this article we review the most compelling evidences on the role of transcription factors such as NF-kappaB and STAT3, cytokines like IL-6 and IL-1alpha, ligands of the EGF receptor and other inflammatory mediators in cancer development, with special emphasis in HCC. The molecular dissection of the pathways connecting the inflammatory reaction and neoplasia will pave the way for better therapies to treat cancers.
Similar articles
- The epidermal growth factor receptor: a link between inflammation and liver cancer.
Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goñi S, Santamaría M, Prieto J, Avila MA. Berasain C, et al. Exp Biol Med (Maywood). 2009 Jul;234(7):713-25. doi: 10.3181/0901-MR-12. Epub 2009 May 8. Exp Biol Med (Maywood). 2009. PMID: 19429859 Review. - Chronic inflammation and hepatocellular carcinoma.
Alison MR, Nicholson LJ, Lin WR. Alison MR, et al. Recent Results Cancer Res. 2011;185:135-48. doi: 10.1007/978-3-642-03503-6_8. Recent Results Cancer Res. 2011. PMID: 21822824 Review. - New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.
Berasain C, Castillo J, Prieto J, Avila MA. Berasain C, et al. Liver Int. 2007 Mar;27(2):174-85. doi: 10.1111/j.1478-3231.2006.01424.x. Liver Int. 2007. PMID: 17311611 Review. - Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer.
Danese S, Mantovani A. Danese S, et al. Oncogene. 2010 Jun 10;29(23):3313-23. doi: 10.1038/onc.2010.109. Epub 2010 Apr 19. Oncogene. 2010. PMID: 20400974 Review. - Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
Elsharkawy AM, Mann DA. Elsharkawy AM, et al. Hepatology. 2007 Aug;46(2):590-7. doi: 10.1002/hep.21802. Hepatology. 2007. PMID: 17661407 Review.
Cited by
- Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study.
Shebl FM, Hsing AW, Park Y, Hollenbeck AR, Chu LW, Meyer TE, Koshiol J. Shebl FM, et al. PLoS One. 2014 Dec 31;9(12):e114633. doi: 10.1371/journal.pone.0114633. eCollection 2014. PLoS One. 2014. PMID: 25551641 Free PMC article. - A Narrative Review on the Specific Pattern of HBV Genotype in Bangladesh: Clinical Implications for Management.
Raihan R, Akbar SMF. Raihan R, et al. Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):152-158. doi: 10.5005/jp-journals-10018-1412. Euroasian J Hepatogastroenterol. 2023. PMID: 38222956 Free PMC article. Review. - Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.
Berasain C, Elizalde M, Urtasun R, Castillo J, García-Irigoyen O, Uriarte I, Latasa MU, Prieto J, Avila MA. Berasain C, et al. Hepat Oncol. 2014 Apr;1(2):241-252. doi: 10.2217/hep.13.17. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190958 Free PMC article. Review. - Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System.
Sotoyama H, Namba H, Tohmi M, Nawa H. Sotoyama H, et al. Biomolecules. 2023 Feb 15;13(2):372. doi: 10.3390/biom13020372. Biomolecules. 2023. PMID: 36830741 Free PMC article. Review. - IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y, Zhang H, Yin J, Xie J, Tan X, Liu S, Zhang Q, Li C, Zhao J, Wang H, Cao G. He Y, et al. Carcinogenesis. 2009 Nov;30(11):1916-22. doi: 10.1093/carcin/bgp226. Epub 2009 Oct 1. Carcinogenesis. 2009. PMID: 19797428 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous